Research strategies to improve snakebite treatment: Challenges and progress
Tóm tắt
Từ khóa
Tài liệu tham khảo
Mohapatra, 2011, Snakebite mortality in India: a nationally representative mortality survey, PLoS Negl Trop Dis, 5, e1018, 10.1371/journal.pntd.0001018
Chippaux, 2011, Estimate of the burden of snakebites in sub-Saharan Africa: a meta-analytic approach, Toxicon, 57, 586, 10.1016/j.toxicon.2010.12.022
Kasturiratne, 2008, The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths, PLoS Med, 5, e218, 10.1371/journal.pmed.0050218
Harrison, 2009, Snake envenoming: a disease of poverty, PLoS Negl Trop Dis, 3, e569, 10.1371/journal.pntd.0000569
WHO
Gutierrez, 2006, Confronting the neglected problem of snake bite envenoming: the need for a global partnership, PLoS Med, 3, e150, 10.1371/journal.pmed.0030150
Gutierrez, 2010, Snakebite envenoming from a global perspective: towards an integrated approach, Toxicon, 56, 1223, 10.1016/j.toxicon.2009.11.020
Williams, 2010, The Global Snake Bite Initiative: an antidote for snake bite, Lancet, 375, 89, 10.1016/S0140-6736(09)61159-4
Stock, 2007, Bringing antivenoms to sub-Saharan Africa, Nat Biotechnol, 25, 173, 10.1038/nbt0207-173
Williams, 2011, Ending the drought: New strategies for improving the flow of affordable, effective antivenoms in Asia and Africa, J Proteomics, 74, 1734, 10.1016/j.jprot.2011.05.027
Gutierrez, 2009, Stability, distribution and use of antivenoms for snakebite envenomation in Latin America: report of a workshop, Toxicon, 53, 625, 10.1016/j.toxicon.2009.01.020
Casewell, 2010, Pre-clinical assays predict pan-African Echis viper efficacy for a species-specific antivenom, PLoS Negl Trop Dis, 4, e851, 10.1371/journal.pntd.0000851
Tanjoni, 2003, Phylogenetic conservation of a snake venom metalloproteinase epitope recognized by a monoclonal antibody that neutralizes hemorrhagic activity, Toxicon, 42, 809, 10.1016/j.toxicon.2003.10.011
Iddon, 1988, Characterisation of a monoclonal antibody capable of neutralising the haemorrhagic activity of West African Echis carinatus (carpet viper) venom, Toxicon, 26, 167, 10.1016/0041-0101(88)90169-9
Perez, 1984, Production of a monoclonal antibody against hemorrhagic activity of Crotalus atrox (western diamondback rattlesnake) venom, Toxicon, 22, 967, 10.1016/0041-0101(84)90188-0
Pukrittayakamee, 1983, Purification and inactivation of the factor X activator of Russell's viper venom with monoclonal antibodies, Mol Biol Med, 1, 123
Fernandes, 2010, Immunochemical and biological characterization of monoclonal antibodies against BaP1, a metalloproteinase from Bothrops asper snake venom, Toxicon, 56, 1059, 10.1016/j.toxicon.2010.07.014
Lomonte, 1992, Neutralization of myotoxic phospholipases A2 from the venom of the snake Bothrops asper by monoclonal antibodies, Toxicon, 30, 239, 10.1016/0041-0101(92)90866-4
Boulain, 1982, Neutralizing monoclonal antibody specific for Naja nigricollis toxin alpha: preparation, characterization, and localization of the antigenic binding site, Biochemistry, 21, 2910, 10.1021/bi00541a016
Tremeau, 1986, A monoclonal antibody which recognized the functional site of snake neurotoxins and which neutralizes all short-chain variants, FEBS Lett, 208, 236, 10.1016/0014-5793(86)81024-9
Menez, 1984, On the molecular mechanisms of neutralization of a cobra neurotoxin by specific antibodies, J Physiol Paris, 79, 196
Pillet, 1992, Anti-idiotypic and anti-anti-idiotypic responses to a monoclonal antibody directed to the acetylcholine receptor binding site of curaremimetic toxins, Biochim Biophys Acta, 1138, 282, 10.1016/0925-4439(92)90005-8
Charpentier, 1990, Recognition of the acetylcholine receptor binding site of a long-chain neurotoxin by toxin-specific monoclonal antibodies, J Mol Recognit, 3, 74, 10.1002/jmr.300030204
Bahraoui, 1988, Monoclonal antibodies to scorpion toxins. Characterization and molecular mechanisms of neutralization, J Immunol, 141, 214, 10.4049/jimmunol.141.1.214
Clot-Faybesse, 1999, Monoclonal antibodies against the Androctonus australis hector scorpion neurotoxin I: characterisation and use for venom neutralisation, FEBS Lett, 458, 313, 10.1016/S0014-5793(99)01179-5
Aubrey, 2003, Design and evaluation of a diabody to improve protection against a potent scorpion neurotoxin, Cell Mol Life Sci, 60, 617, 10.1007/s000180300053
Devaux, 2001, Construction and functional evaluation of a single-chain antibody fragment that neutralizes toxin AahI from the venom of the scorpion Androctonus australis hector, Eur J Biochem, 268, 694, 10.1046/j.1432-1327.2001.01923.x
Juarez-Gonzalez, 2005, Directed evolution, phage display and combination of evolved mutants: a strategy to recover the neutralization properties of the scFv version of BCF2 a neutralizing monoclonal antibody specific to scorpion toxin Cn2, J Mol Biol, 346, 1287, 10.1016/j.jmb.2004.12.060
Juste, 2007, Using a recombinant bispecific antibody to block Na+-channel toxins protects against experimental scorpion envenoming, Cell Mol Life Sci, 64, 206, 10.1007/s00018-006-6401-3
Mousli, 1999, A recombinant single-chain antibody fragment that neutralizes toxin II from the venom of the scorpion Androctonus australis hector, FEBS Lett, 442, 183, 10.1016/S0014-5793(98)01647-0
Espino-Solis, 2009, Antidotes against venomous animals: state of the art and prospectives, J Proteomics, 72, 183, 10.1016/j.jprot.2009.01.020
Abubakar, 2010, Pre-clinical and preliminary dose-finding and safety studies to identify candidate antivenoms for treatment of envenoming by saw-scaled or carpet vipers (Echis ocellatus) in northern Nigeria, Toxicon, 55, 719, 10.1016/j.toxicon.2009.10.024
Harrison, 2000, Antibody from mice immunized with DNA encoding the carboxyl-disintegrin and cysteine-rich domain (JD9) of the haemorrhagic metalloprotease, Jararhagin, inhibits the main lethal component of viper venom, Clin Exp Immunol, 121, 358, 10.1046/j.1365-2249.2000.01287.x
Wagstaff, 2006, Venom gland EST analysis of the saw-scaled viper, Echis ocellatus, reveals novel alpha9beta1 integrin-binding motifs in venom metalloproteinases and a new group of putative toxins, renin-like aspartic proteases, Gene, 377, 21, 10.1016/j.gene.2006.03.008
Harrison, 2003, The conserved structure of snake venom toxins confers extensive immunological cross-reactivity to toxin-specific antibody, Toxicon, 41, 441, 10.1016/S0041-0101(02)00360-4
Harrison, 2004, Development of venom toxin-specific antibodies by DNA immunisation: rationale and strategies to improve therapy of viper envenoming, Vaccine, 22, 1648, 10.1016/j.vaccine.2003.09.046
Alvarenga, 2005, Molecular characterization of a neutralizing murine monoclonal antibody against Tityus serrulatus scorpion venom, Toxicon, 46, 664, 10.1016/j.toxicon.2005.07.014
Calderon-Aranda, 1999, Mapping of an epitope recognized by a neutralizing monoclonal antibody specific to toxin Cn2 from the scorpion Centruroides noxius, using discontinuous synthetic peptides, Eur J Biochem, 264, 746, 10.1046/j.1432-1327.1999.00620.x
Gazarian, 2005, Immunology of scorpion toxins and perspectives for generation of anti-venom vaccines, Vaccine, 23, 3357, 10.1016/j.vaccine.2004.12.027
Licea, 1996, Fab fragments of the monoclonal antibody BCF2 are capable of neutralizing the whole soluble venom from the scorpion Centruroides noxius Hoffmann, Toxicon, 34, 843, 10.1016/0041-0101(96)00043-8
Alvarenga, 2003, Production of monoclonal antibodies capable of neutralizing dermonecrotic activity of Loxosceles intermedia spider venom and their use in a specific immunometric assay, Toxicon, 42, 725, 10.1016/j.toxicon.2003.09.006
Guilherme, 2001, Neutralization of dermonecrotic and lethal activities and differences among 32–35kDa toxins of medically important Loxosceles spider venoms in Brazil revealed by monoclonal antibodies, Toxicon, 39, 1333, 10.1016/S0041-0101(01)00085-X
Strand, 1994, Development and partial characterization of monoclonal antibodies to venom of the parasitoid Microplitis demolitor, Arch Insect Biochem Physiol, 26, 123, 10.1002/arch.940260206
Li, 1993, Cross-reactivities of monoclonal antibodies to a myotoxin from the venom of the broad-banded copperhead (Agkistrodon contortrix laticinctus), Toxicon, 31, 1187, 10.1016/0041-0101(93)90134-5
Estevao-Costa, 2000, Neutralization of the hemorrhagic activity of Bothrops and Lachesis snake venoms by a monoclonal antibody against mutalysin-II, Toxicon, 38, 139, 10.1016/S0041-0101(99)00134-8
St Pierre, 2005, Identification and analysis of venom gland-specific genes from the coastal taipan (Oxyuranus scutellatus) and related species, Cell Mol Life Sci, 62, 2679, 10.1007/s00018-005-5384-9
Leao, 2009, Transcriptomic basis for an antiserum against Micrurus corallinus (coral snake) venom, BMC Genomics, 10, 112, 10.1186/1471-2164-10-112
Cidade, 2006, Bothrops jararaca venom gland transcriptome: analysis of the gene expression pattern, Toxicon, 48, 437, 10.1016/j.toxicon.2006.07.008
Junqueira-de-Azevedo Ide, 2002, A survey of gene expression and diversity in the venom glands of the pitviper snake Bothrops insularis through the generation of expressed sequence tags (ESTs), Gene, 299, 279, 10.1016/S0378-1119(02)01080-6
Kashima, 2004, Analysis of Bothrops jararacussu venomous gland transcriptome focusing on structural and functional aspects: I — gene expression profile of highly expressed phospholipases A2, Biochimie, 86, 211, 10.1016/j.biochi.2004.02.002
Boldrini-Franca, 2009, Crotalus durissus collilineatus venom gland transcriptome: analysis of gene expression profile, Biochimie, 91, 586, 10.1016/j.biochi.2009.02.001
Casewell, 2009, Comparative venom gland transcriptome surveys of the saw-scaled vipers (Viperidae: Echis) reveal substantial intra-family gene diversity and novel venom transcripts, BMC Genomics, 10, 564, 10.1186/1471-2164-10-564
Zhang, 2006, Transcriptome analysis of Deinagkistrodon acutus venomous gland focusing on cellular structure and functional aspects using expressed sequence tags, BMC Genomics, 7, 152, 10.1186/1471-2164-7-152
Jiang, 2011, Venom gland transcriptomes of two elapid snakes (Bungarus multicinctus and Naja atra) and evolution of toxin genes, BMC Genomics, 12, 1, 10.1186/1471-2164-12-1
Wagstaff, 2009, Combined snake venomics and venom gland transcriptomic analysis of the ocellated carpet viper, Echis ocellatus, J Proteomics, 71, 609, 10.1016/j.jprot.2008.10.003
Wagstaff, 2006, Bioinformatics and multiepitope DNA immunization to design rational snake antivenom, PLoS Med, 3, e184, 10.1371/journal.pmed.0030184
Alvarenga, 2010, Design of antibody-reactive peptides from discontinuous parts of scorpion toxins, Vaccine, 28, 970, 10.1016/j.vaccine.2009.10.135
Arce-Estrada, 2009, Neutralization of venom-induced hemorrhage by equine antibodies raised by immunization with a plasmid encoding a novel P-II metalloproteinase from the lancehead pitviper Bothrops asper, Vaccine, 27, 460, 10.1016/j.vaccine.2008.10.066
Azofeifa-Cordero, 2008, Immunization with cDNA of a novel P-III type metalloproteinase from the rattlesnake Crotalus durissus durissus elicits antibodies which neutralize 69% of the hemorrhage induced by the whole venom, Toxicon, 52, 302, 10.1016/j.toxicon.2008.05.023
Lalloo, 2003, Snake antivenoms, J Toxicol Clin Toxicol, 41, 317
dos Santos, 1989, Purification of F(ab′)2 anti-snake venom by caprylic acid: a fast method for obtaining IgG fragments with high neutralization activity, purity and yield, Toxicon, 27, 297, 10.1016/0041-0101(89)90177-3
Rojas, 1994, Caprylic acid fractionation of hyperimmune horse plasma: description of a simple procedure for antivenom production, Toxicon, 32, 351, 10.1016/0041-0101(94)90087-6
Burnouf, 2000, Reducing the risk of infection from plasma products: specific preventative strategies, Blood Rev, 14, 94, 10.1054/blre.2000.0129
Hamers-Casterman, 1993, Naturally occurring antibodies devoid of light chains, Nature, 363, 446, 10.1038/363446a0
Herrera, 2005, Factors associated with adverse reactions induced by caprylic acid-fractionated whole IgG preparations: comparison between horse, sheep and camel IgGs, Toxicon, 46, 775, 10.1016/j.toxicon.2005.08.004
Meddeb-Mouelhi, 2003, Immunized camel sera and derived immunoglobulin subclasses neutralizing Androctonus australis hector scorpion toxins, Toxicon, 42, 785, 10.1016/j.toxicon.2003.10.021
Harrison, 2006, Neutralisation of venom-induced haemorrhage by IgG from camels and llamas immunised with viper venom and also by endogenous, non-IgG components in camelid sera, Toxicon, 47, 364, 10.1016/j.toxicon.2005.10.017
Lauwereys, 1998, Potent enzyme inhibitors derived from dromedary heavy-chain antibodies, EMBO J, 17, 3512, 10.1093/emboj/17.13.3512
De Genst, 2006, Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies, Proc Natl Acad Sci USA, 103, 4586, 10.1073/pnas.0505379103
Pratanaphon, 1997, Production of highly potent horse antivenom against the Thai cobra (Naja kaouthia), Vaccine, 15, 1523, 10.1016/S0264-410X(97)00098-4
Chinonavanig, 1988, Antigenic relationships and relative immunogenicities of venom proteins from six poisonous snakes of Thailand, Toxicon, 26, 883, 10.1016/0041-0101(88)90329-7
Omidfar, 2007, Studies of thermostability in Camelus bactrianus (Bactrian camel) single-domain antibody specific for the mutant epidermal-growth-factor receptor expressed by Pichia, Biotechnol Appl Biochem, 46, 41, 10.1042/BA20060104
Cook, 2010, Analysis of camelid IgG for antivenom development: serological responses of venom-immunised camels to prepare either monospecific or polyspecific antivenoms for West Africa, Toxicon, 56, 363, 10.1016/j.toxicon.2010.03.025
Cook, 2010, Analysis of camelid IgG for antivenom development: immunoreactivity and preclinical neutralisation of venom-induced pathology by IgG subclasses, and the effect of heat treatment, Toxicon, 56, 596, 10.1016/j.toxicon.2010.06.004
Cook, 2010, Analysis of camelid antibodies for antivenom development: neutralisation of venom-induced pathology, Toxicon, 56, 373, 10.1016/j.toxicon.2010.04.005
Fernandez, 2010, Neutralization of Bothrops mattogrossensis snake venom from Bolivia: experimental evaluation of llama and donkey antivenoms produced by caprylic acid precipitation, Toxicon, 55, 642, 10.1016/j.toxicon.2009.07.031
Warrell, 1976, Necrosis, haemorrhage and complement depletion following bites by the spitting cobra (Naja nigricollis), Q J Med, 45, 1
Warrell, 1977, Poisoning by bites of the saw-scaled or carpet viper (Echis carinatus) in Nigeria, Q J Med, 46, 33
Mion, 1997, Envenimations par vipéridés en Afrique Noire, 349
Einterz, 2003, Snakebite in northern Cameroon: 134 victims of bites by the saw-scaled or carpet viper, Echis ocellatus, Trans R Soc Trop Med Hyg, 97, 693, 10.1016/S0035-9203(03)80105-0
Trape, 2001, High mortality from snakebite in south-eastern Senegal, Trans R Soc Trop Med Hyg, 95, 420, 10.1016/S0035-9203(01)90202-0
Gutierrez, 2000, Snake venom metalloproteinases: their role in the pathogenesis of local tissue damage, Biochimie, 82, 841, 10.1016/S0300-9084(00)01163-9
Gutierrez, 2007, Trends in snakebite envenomation therapy: scientific, technological and public health considerations, Curr Pharm Des, 13, 2935, 10.2174/138161207782023784
Jimenez, 2008, Skin pathology induced by snake venom metalloproteinase: acute damage, revascularization, and re-epithelization in a mouse ear model, J Invest Dermatol, 128, 2421, 10.1038/jid.2008.118
Mora, 2005, A Lys49 phospholipase A(2) homologue from Bothrops asper snake venom induces proliferation, apoptosis and necrosis in a lymphoblastoid cell line, Toxicon, 45, 651, 10.1016/j.toxicon.2005.01.008
Perez, 2007, Local and systemic pathophysiological alterations induced by a serine proteinase from the venom of the snake Bothrops jararacussu, Toxicon, 49, 1063, 10.1016/j.toxicon.2006.12.011
Imkhieo, 2009, Pig as an experimental model for the study of snake venom induced local tissue necrosis, Toxicon, 53, 317, 10.1016/j.toxicon.2008.12.001
Gutierrez, 1998, Neutralization of local tissue damage induced by Bothrops asper (terciopelo) snake venom, Toxicon, 36, 1529, 10.1016/S0041-0101(98)00145-7
Leon, 2000, Comparative study on the ability of IgG and Fab sheep antivenoms to neutralize local hemorrhage, edema and myonecrosis induced by Bothrops asper (terciopelo) snake venom, Toxicon, 38, 233, 10.1016/S0041-0101(99)00152-X
Dart, 2001, A randomized multicenter trial of crotalinae polyvalent immune Fab (ovine) antivenom for the treatment for crotaline snakebite in the United States, Arch Intern Med, 161, 2030, 10.1001/archinte.161.16.2030
Bode, 1993, Astacins, serralysins, snake venom and matrix metalloproteinases exhibit identical zinc-binding environments (HEXXHXXGXXH and Met-turn) and topologies and should be grouped into a common family, the ‘metzincins’, FEBS Lett, 331, 134, 10.1016/0014-5793(93)80312-I
Escalante, 2000, Effectiveness of batimastat, a synthetic inhibitor of matrix metalloproteinases, in neutralizing local tissue damage induced by BaP1, a hemorrhagic metalloproteinase from the venom of the snake bothrops asper, Biochem Pharmacol, 60, 269, 10.1016/S0006-2952(00)00302-6
Rucavado, 2000, Inhibition of local hemorrhage and dermonecrosis induced by Bothrops asper snake venom: effectiveness of early in situ administration of the peptidomimetic metalloproteinase inhibitor batimastat and the chelating agent CaNa2EDTA, Am J Trop Med Hyg, 63, 313, 10.4269/ajtmh.2000.63.313
Rucavado, 2004, Effect of the metalloproteinase inhibitor batimastat in the systemic toxicity induced by Bothrops asper snake venom: understanding the role of metalloproteinases in envenomation, Toxicon, 43, 417, 10.1016/j.toxicon.2004.01.016
Angulo, 2003, Inhibitory effect of fucoidan on the activities of crotaline snake venom myotoxic phospholipases A(2), Biochem Pharmacol, 66, 1993, 10.1016/S0006-2952(03)00579-3
Moura-da-Silva, 1996, Processing of pro-tumor necrosis factor-alpha by venom metalloproteinases: a hypothesis explaining local tissue damage following snake bite, Eur J Immunol, 26, 2000, 10.1002/eji.1830260905
Laing, 2003, Inflammatory pathogenesis of snake venom metalloproteinase-induced skin necrosis, Eur J Immunol, 33, 3458, 10.1002/eji.200324475
Neves-Ferreira, 2010, Natural inhibitors: innate immunity to snake venoms, 259
Kemperaju, 2010, Hyaluronidases, a neglected class of glycosidases from snake venom: beyond a spreading factor, 237
Desmyter, 1996, Crystal structure of a camel single-domain VH antibody fragment in complex with lysozyme, Nat Struct Biol, 3, 803, 10.1038/nsb0996-803
Abderrazek, 2009, Identification of potent nanobodies to neutralize the most poisonous polypeptide from scorpion venom, Biochem J, 424, 263, 10.1042/BJ20090697
Coppieters, 2006, Formatted anti-tumor necrosis factor alpha VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen-induced arthritis, Arthritis Rheum, 54, 1856, 10.1002/art.21827
Harmsen, 2009, Passive immunization with llama single-domain antibody fragments reduces foot-and-mouth disease transmission between pigs, Vaccine, 27, 1904, 10.1016/j.vaccine.2009.01.110
2011
Hmila, 2008, VHH, bivalent domains and chimeric heavy chain-only antibodies with high neutralizing efficacy for scorpion toxin AahI′, Mol Immunol, 45, 3847, 10.1016/j.molimm.2008.04.011
Hultberg, 2011, Llama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral molecules, PLoS One, 6, e17665, 10.1371/journal.pone.0017665
Tremblay, 2010, Camelid single domain antibodies (VHHs) as neuronal cell intrabody binding agents and inhibitors of Clostridium botulinum neurotoxin (BoNT) proteases, Toxicon, 56, 990, 10.1016/j.toxicon.2010.07.003
Tijink, 2008, Improved tumor targeting of anti-epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody technology, Mol Cancer Ther, 7, 2288, 10.1158/1535-7163.MCT-07-2384
Wesolowski, 2009, Single domain antibodies: promising experimental and therapeutic tools in infection and immunity, Med Microbiol Immunol, 198, 157, 10.1007/s00430-009-0116-7
Chotwiwatthanakun, 2001, Production of potent polyvalent antivenom against three elapid venoms using a low dose, low volume, multi-site immunization protocol, Toxicon, 39, 1487, 10.1016/S0041-0101(01)00108-8
Sunthornandh, 1994, A comparative study of three vehicles on antibody responses against elapid snake neurotoxin immunogens, Toxicon, 32, 561, 10.1016/0041-0101(94)90204-6
Waghmare, 2009, Comparison of Montanide adjuvants, IMS 3012 (Nanoparticle), ISA 206 and ISA 35 (Emulsion based) along with incomplete Freund's adjuvant for hyperimmunization of equines used for production of polyvalent snake antivenom, Vaccine, 27, 1067, 10.1016/j.vaccine.2008.11.103
Harrison, 2007, The unique properties of camelid IgG have potential to improve the treatment of snake bite, J Camel Pract Res, 14, 15
Calvete, 2010, Antivenomic assessment of the immunological reactivity of EchiTAb-Plus-ICP, an antivenom for the treatment of snakebite envenoming in sub-Saharan Africa, Am J Trop Med Hyg, 82, 1194, 10.4269/ajtmh.2010.09-0733
Segura, 2010, Preclinical assessment of the efficacy of a new antivenom (EchiTAb-Plus-ICP) for the treatment of viper envenoming in sub-Saharan Africa, Toxicon, 55, 369, 10.1016/j.toxicon.2009.08.010
Rodrigues-Silva, 1997, Purification and stability studies of immunoglobulins from Lachesis muta muta antivenom, Toxicon, 35, 1229, 10.1016/S0041-0101(97)00015-9
Rodrigues-Silva, 1999, Thermal stability studies of hyperimmune horse antivenoms, Toxicon, 37, 33, 10.1016/S0041-0101(97)00101-3
Leon, 2009, Stability of equine IgG antivenoms obtained by caprylic acid precipitation: towards a liquid formulation stable at tropical room temperature, Toxicon, 53, 609, 10.1016/j.toxicon.2009.01.012
WHO